Nutrición hospitalaria: Órgano oficial de la Sociedad Española de Nutrición Clínica y Metabolismo (SENPE)

• 

  Año 2013, Vol. 28, Número Extraordinario 2. Dedicado a: CIRUGÍA DIABETES IMC 24-34; ¿CÓMO Y POR QUÉ?

  • Diabetes surgery: minimum information on diabetic patients sample BMI 24-29 or BMI 30-34 for doing studies comparable

    Manuel García Caballero

    págs. 1-2

    

  • Current medical treatment of diabetes type 2 and long term morbidity: how to balance efficacy and safety?

    Carlos A. Carrera Boada, José Manuel Martínez Moreno

    • Resumen

    págs. 3-13

    

  • Metabolic surgery: who and when? Is there a good answer?

    Ricardo Cohen

    • Resumen

    págs. 14-16

    

  • Management of patients with type 2 diabetes before and after bariatric surgery: evolution and microvascular complications

    Ling Ling Chuah, Carel W. le Roux

    • Resumen

    págs. 17-22

    

  • Diabetes surgery in type 2 BMI 24-29 vs IMC 30-34 diabetic patients: is there differences among restrictive, malabsorptive and gastric bypass procedures?

    Manuel García Caballero, Salvador Navarrete Aulestia, Franco Favretti, Alper Celik, Daniel del Castillo Déjardin

    • Resumen

    págs. 23-30

    

  • Obesity and metabolic surgery in type 1 diabetes mellitus

    Heike Raab, R. A. Weiner, M. Frenken, K. Rett, S. Weiner

    • Resumen

    págs. 31-34

    

  • Improvement of C peptide zero BMI 24-34 diabetic patients after tailored one anastomosis gastric bypass (BAGUA)

    Manuel García Caballero, José Manuel Martínez Moreno, José Antonio Toval Mata, Francisco Miralles Linares, Alfredo Mínguez Mañanes, Diego Osorio Fernández, José María Mata Martín, Alexander Reyes Ortiz

    • Resumen

    págs. 35-46

    

  • Morbidity and mortality of diabetes with surgery

    Ling Ling Chuah, Dimitrios K Papamargaritis, D. Pillai, A. Krishnamoorthy, Carel W. le Roux

    • Resumen

    págs. 47-52

    

  • Diabetic retinopathy

    Antonio Moreno Guerrero, M. Lozano, Pablo Salinas Sánchez

    • Resumen

    págs. 53-56

    

  • Diabetic nephropathy: changes after diabetes surgery?

    Silvia Ros Ruiz

    • Resumen

    págs. 57-65

    

  • Quality of life of diabetic patients with medical or surgical treatment

    S. Weiner, E. A. M. Neugehauer

    • Resumen

    págs. 66-77

    

  • Pathophysiology of diabetes mellitus type 2: beyond the duo �insulin resistance-secretion deficit�

    Carlos A. Carrera Boada, José Manuel Martínez Moreno

    • Resumen

    págs. 78-87

    

  • Influences of the diabetes surgery on pancreatic ß-cells mass

    José Manuel Martínez Moreno, Manuel García Caballero

    • Resumen

    págs. 88-94

    

  • Influence of diabetes surgery on gut hormones and incretins

    Dimitrios K Papamargaritis, A. D. Miras, Carel W. le Roux

    • Resumen

    págs. 95-103

    

  • Other aspects of bariatric surgery: liver steatosis, ferritin and cholesterol metabolism

    Antonio E. Pontiroli, A. Benetti (col.), L. Folini (col.), C. Merlotti (col.), F. Frigè (col.)

    • Resumen

    págs. 104-108

    

  • Influence of diabetes surgery on a gut-brain-liver axis regulating food intake and internal glucose production

    Gilles Mithieux

    • Resumen

    págs. 109-114